Science Board Advises FDA To Prioritize Cross-Cutting Science Initiatives
This article was originally published in The Gray Sheet
Executive Summary
No device center research projects were labeled as a top priority by FDA's Science Board at a May 18 gathering. A board subcommittee suggested instead that the agency should focus its limited resources on science projects that cut across product centers and cannot be conducted by an outside organization